It floated last autumn after a bumper period of fundraisings and other deals and did warn that it would not achieve the same levels of revenues and profit, but it turned out worse than expected due to delayed deals. None more so than broker Peel Hunt (LSE:PEEL). Some companies joined AIM when their markets were peaking. The previously mentioned ATOME Energy, which was spun out of President Energy (LSE:PPC), has risen by 17.5% although the share price has been highly volatile. Acquisitions have helped to enhance the business, although the share price is well below its high. The flip side was the potential to secure sites at attractive rents. It floated at the beginning of 2021 when investors were required to be brave to be putting their money into bars and restaurants when lockdowns where still in force. In contrast, bars operator Nightcap (LSE:NGHT) is 45% higher. Laboratories and pharma offices investor Life Science REIT (LSE:LABS), a more solid investment, has drifted lower by 5.9%. Technology investor Forward Partners (LSE:FWD) has fallen 54.5% and biotech Poolbeg Pharma (LSE:POLB), which was spun out of Open Orphan (LSE:ORPH), is 53% lower. This is an example of a high-profile business attracting investors at a premium valuation and failing to live up to optimistic expectations. The worst-performing new admission from last year is delivered meals provider Parsley Box (LSE:MEAL), which offered shares via PrimaryBid and the share price has dived by 95.1%. This shows that investors need to be choosy. Six of these AIM companies that joined AIM in 2021 offered small investors the chance to be involved in their flotations, but the outcomes have not been that good to say the least. Investors are keen to gain access to new companies joining the London markets. There are 11 companies where share prices have risen during 2022 and three of those are still below their flotation prices.
0 Comments
Leave a Reply. |